drugset
drugset / Trial / NCT00692250

A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers

NCT00692250 ↗

Phase 1 Completed 14 enrolled Genzyme, a Sanofi Company
RandomizedParallel-groupOpen-label

Summary

This study is designed to assess any potential interaction between colesevelam and ciclosporin in healthy volunteers.

Timeline

Start
2007-09
Primary completion
—
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified — —

Indications

No indication recorded.